Gut Permeability and Microbiota in Parkinson’s Disease: Mechanistic Insights and Experimental Therapeutic Strategies

Globally, Parkinson’s disease (PD) is the neurodegenerative condition with the most rapidly increasing prevalence, and a growing body of evidence associates its pathology with impairments in the gut–brain axis. Traditionally viewed as a disease marked by the loss of dopaminergic neurons, emerging ev...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	International journal of molecular sciences Ročník 26; číslo 19; s. 9593
Hlavní autoři:	Liang, Yicheng, Zhao, Yuhang, Fasano, Alessio, Su, Chien-Wen
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Switzerland MDPI AG 01.10.2025
Témata:	alpha-Synuclein - metabolism Animals Blood-Brain Barrier - metabolism Celiac disease Cytokines Development and progression Fatty acids Gastrointestinal Microbiome - physiology Gluten Gut microbiota Health aspects Homeostasis Humans Hypotheses Inflammation Kinases Metabolites Microbiota (Symbiotic organisms) Neurodegeneration Neurons Parkinson Disease - metabolism Parkinson Disease - microbiology Parkinson Disease - therapy Parkinson's disease Pathogens Pathology Patients Peptides Permeability Proteins Stem cells Toxins Type 2 diabetes Massachusetts gut permeability neuroinflammation Parkinson’s disease (PD) leaky gut therapeutic approaches gut microbiota personalized therapy
ISSN:	1422-0067, 1661-6596, 1422-0067
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!